The landscape of genetic testing for hereditary breast and ovarian cancer has substantially evolved over the past 30 years. This session will take you on a journey from single gene testing to multigene panel testing, highlighting key events along the way. With experience in clinical and molecular genetics, Dr. Chao is uniquely positioned to provide insights into the factors that have shaped genetic testing for this condition and the way changes in testing have impacted patient care.
Level of instruction: intermediate
Only the live session qualifies for CEUs but when possible, we host the recordings on our website and NSGC recommends participants to use their personal email instead of work email addresses to ensure they receive their CEU certificates.
Ambry Genetics is approved as a provider for continuing education program by NSGC and ASCLS P.A.C.E ® Program.